GLP-1 Peptide Reviews: The Real Story Behind Weight Loss Claims in 2026

If you've spent any time on social media lately, you've probably seen ads for "GLP-1" drops promising Ozempic-style results without a prescription. Names like Diapason GLP-1 and Lercea GLP-1 come up again and again, usually alongside glowing reviews and dramatic before-and-after photos. It's easy to see the appeal when prescription medications cost hundreds of dollars a month.

This guide gives you the real story, updated for 2026. We'll look at what's actually in these drops, whether there's any evidence they work, and how the approved medications compare when you look at the clinical trials. We'll also cover the red flags that should make you close the tab.

Quick Answer: Does Diapason GLP-1 Work?

There's no published evidence that it does. When we searched PubMed and ClinicalTrials.gov in September 2026, we found no studies of Diapason GLP-1 for weight loss or anything else. A retailer listing for the product describes it as a liquid supplement containing herbal ingredients, and says it is "not specifically FDA approved."

The GLP-1 medications that have been shown to cause meaningful weight loss in clinical trials are prescription drugs. A supplement that borrows the name isn't the same thing, and there's no data showing it works like one.

Not All "GLP-1" Products Are Created Equal

Here's what most ads won't tell you: "GLP-1" is the name of a hormone and of a class of prescription drugs that act like it. It isn't a protected label. Anyone can put those letters on a bottle of drops. Think of it like comparing a Ferrari to a toy car that happens to have four wheels. They might look similar in a photo, but they aren't built for the same job.

Prescription GLP-1 receptor agonists such as semaglutide and tirzepatide go through large randomized trials before the FDA approves them. Their labels spell out what they're approved for, what the trials found, and what the risks are. A dietary supplement doesn't go through that process at all.

The FDA is clear about this. In its own words, "FDA does not have the authority to approve dietary supplements before they are marketed" (FDA, Questions and Answers on Dietary Supplements). Supplement makers are still responsible for their claims. The same FDA page says that when a company makes a claim about how a product affects the body, "the firm must have substantiation that the claim is truthful and not misleading." But nobody checks that evidence before the product goes on sale.

Diapason GLP-1 Reviews: What's Actually in the Bottle

We couldn't find a verified manufacturer website for Diapason GLP-1, so the details below come from a retailer listing for "Diapason GLP-1 Oral Solution" (Tutela Medical listing). The listing names the brand as HHVB and prices it at $15.99 and up.

The form. It's described as a "liquid drop formulation," taken by mouth.

The ingredients. The listing names "Meglitude GLP-1, Moringa, Apple Cider Vinegar, Turmeric, Ginkgo Biloba Extract, Echinacea, and Probiotics," and also mentions green tea extract, NAD and NMN.

The claims. It talks about "appetite regulation" and "enhanced metabolic functions."

The disclaimer. The listing itself says the product is "not specifically FDA approved."

The headline ingredient is "Meglitude GLP-1." It sounds like a drug name, but a PubMed search for "meglitude" returns zero results. We couldn't find any published description of what it is or how much of it is in each bottle. The rest of the list is made up of common supplement ingredients. None of them is an FDA-approved GLP-1 medication.

What About All Those Positive Reviews?

Online reviews for supplements like this are hard to trust, and that's not just cynicism. In December 2025, the FTC finalized an order against a telehealth weight-loss company, NextMed, over allegations that included unsubstantiated weight-loss claims, "fake testimonials," and distorted reviews (FTC press release). That case wasn't about Diapason, but it shows how weight-loss reviews can be manufactured.

A five-star rating tells you someone was happy, or that someone wanted the product to look popular. It doesn't tell you whether the product caused weight loss. For that, you need a controlled trial, where one group takes the product and another takes a placebo, and nobody knows who got which.

Does Diapason GLP-1 Work? Our Verdict

Based on what's publicly available, there's no evidence that Diapason GLP-1 causes weight loss. We can't prove it does nothing, since nobody has studied it. But the burden of proof is on the seller, and there's nothing to point to.

You also have no reason to expect results like the ones seen with prescription GLP-1 drugs. Those results came from specific molecules, at specific doses, tested in thousands of people. A bottle of drops with an unidentified "GLP-1" ingredient isn't a substitute.

If you take other medications, check with a pharmacist before adding any supplement, including this one. And if you've already bought it, don't let the cost push you into continuing. Money spent on something without evidence isn't a saving.

Lercea GLP-1: Same Pattern, Bolder Claims

Lercea sells several "GLP-1" drops. Its own product page for Lercea GLP-1 Moringa Slimming & Health Boost Drops (Lercea) is worth reading closely, because the claims unravel quickly.

The ingredients. The page lists "GLP-1(Meglutide), Moringa, Peppermint essential oil, MCT oil, Citron essential oil, Stevia."

The "GLP-1" ingredient. The page says "Meglutide is a product created based on simethicone." Simethicone is an over-the-counter medicine used to treat the symptoms of gas, such as pressure, fullness and bloating (MedlinePlus). It isn't a GLP-1 drug. A PubMed search for "meglutide" returns zero results.

The fat-burning claim. The page claims that "5ml of GLP-1 Drops Solution can burn up to about 100 grams of stubborn fat." We found no study supporting that.

The endorsement. The page says the drops were "developed by The Obesity Society." The Obesity Society is a professional scientific organization, and the only place we found this claim was on Lercea's own site.

The FDA claim. The page's FAQ says the product "has passed FDA certification and clinical testing." As the FDA itself explains, it doesn't approve supplements before they're sold, and we found no published clinical trials of these drops.

The drops sell for between $16.95 and $40.95 depending on the bundle. Our verdict is the same as for Diapason: no evidence it works, and several claims that should make you walk away.

Now Let's Talk About What Actually Works

After the drops, let's shift to the medications that have transformed weight-loss treatment. They aren't perfect. They cost real money, they need a prescription and medical supervision, and they have side effects. But they're backed by large trials published in major journals.

Here's how the main options compare, using the average results reported in each drug's key trial.

Keep in mind that these are averages from different trials with different people, so they aren't a perfect head-to-head comparison (except SURMOUNT-5, which compared tirzepatide and semaglutide directly). Some people lose much more, and some lose much less.

Tirzepatide (Zepbound and Mounjaro): The Current Leader

Tirzepatide acts on two hormone receptors, GIP and GLP-1, instead of just one. It's sold as Zepbound for weight management and as Mounjaro for type 2 diabetes.

The results. In SURMOUNT-5, a head-to-head trial published in the New England Journal of Medicine, people taking tirzepatide lost an average of 20.2% of their body weight at week 72, compared with 13.7% for people taking semaglutide (Aronne et al., NEJM 2025). For someone starting at 200 pounds, that's roughly 40.4 pounds versus 27.4 pounds, a gap of about 13 pounds.

Other uses. The Zepbound label also includes treatment of "moderate to severe obstructive sleep apnea (OSA) in adults with obesity" (Zepbound label).

The trade-offs. Like all drugs in this class, it commonly causes digestive side effects, especially as the dose goes up. We cover those below.

Semaglutide (Wegovy and Ozempic): The Proven Performer

Semaglutide put GLP-1 therapy on the map. It's sold as Wegovy for weight management and as Ozempic for type 2 diabetes, and it has the longest track record of the newer options.

The results. In STEP 1, adults taking semaglutide 2.4 mg lost an average of 14.9% of their body weight at week 68, compared with 2.4% on placebo (Wilding et al., NEJM 2021).

Heart benefits. Wegovy's label includes an indication "to reduce the risk of major adverse cardiovascular (CV) events" in adults with established cardiovascular disease (Wegovy label).

More ways to take it. Wegovy now comes as a weekly injection, a higher-dose Wegovy HD injection at 7.2 mg, and a Wegovy pill in 1.5 mg, 4 mg, 9 mg and 25 mg tablets. Which form fits you, and at what dose, is a decision for your prescriber.

Orforglipron (Foundayo): The Newest Pill

Foundayo (orforglipron) is Lilly's GLP-1 pill for weight loss, approved by the FDA on April 1, 2026. In the ATTAIN-1 trial, people on the highest dose lost an average of "27.3 pounds (12.4%)" over 72 weeks, according to Lilly (Lilly press release). Lilly says self-pay pricing starts at $149 a month for the lowest dose.

The average result is smaller than with the injectable options in the table. For some people, the convenience of a pill and the lower starting price may matter more, and that's a conversation worth having with your prescriber.

Liraglutide (Saxenda): Modest but Established

Liraglutide was one of the first GLP-1 medications approved for weight management. It's injected daily rather than weekly, and its average results are more modest.

In the SCALE trial, people taking liraglutide 3 mg lost an average of 8.4 kg (about 18.5 pounds) at week 56, compared with 2.8 kg (about 6.2 pounds) on placebo (Pi-Sunyer et al., NEJM 2015). That's meaningful, even if the newer options usually do better.

What About Retatrutide?

You may have seen retatrutide, sometimes nicknamed "GLP-3," sold online as powder vials. It's an investigational drug and isn't FDA approved for any use. In May 2026, Lilly reported that people on the highest dose in its TRIUMPH-1 trial lost an average of 28.3% of their body weight at 80 weeks (Lilly press release), and it plans to apply for FDA approval in early 2027.

Vials sold online today don't come from that trial. The FDA has warned about unapproved GLP-1 products "falsely labeled 'for research purposes' or 'not for human consumption'" (FDA). We don't recommend buying them. Our retatrutide guide explains where it stands.

Side Effects Are Part of the Deal

The approved medications work, but they aren't gentle. The Zepbound and Wegovy labels both list nausea, diarrhea, vomiting and constipation among the most common side effects. These tend to be worst when you're starting or moving up a dose.

Both labels also carry a boxed warning about thyroid C-cell tumors, which were seen in rodent studies. Your prescriber will ask about your personal and family history of certain thyroid cancers before starting you on one. This is one of many reasons these drugs need a prescription and follow-up, not a shopping cart.

If you're already on a GLP-1 and struggling, our practical guide to managing GLP-1 side effects covers what helps.

The Honest Conversation About Costs

Money is the biggest reason the drops are tempting. In 2026, self-pay prices for the approved GLP-1 medications range between $149 and $499 a month depending on the drug and dose, and eligible Medicare Part D enrollees can pay a $50 monthly copay under the new Medicare GLP-1 Bridge. Our peptide therapy cost guide breaks down every option.

Compared with that, a $16 bottle of drops looks like a bargain. But here's the hard truth: a cheap product that doesn't work isn't cheaper. It's just a smaller loss, plus the months you could have spent on something with evidence behind it.

What About Tracking Your Progress?

Whatever you and your prescriber decide on, keeping records makes a real difference. Tracking your doses, weight, side effects and how you feel gives your prescriber something concrete to work with at each visit. It also helps you spot patterns, like nausea that's always worse the day after an injection.

PeptideKit lets you log each dose, keep notes on side effects, and set dose reminders so you don't miss a week. If you're working with a compounded vial, its built-in calculator turns your prescribed dose into syringe units, so you're not doing the math in your head.

Red Flags to Watch For

Before you buy any product with "GLP-1" on the label, watch for these warning signs.

"GLP-1" on a product you can buy without a prescription. The FDA-approved GLP-1 medications are prescription drugs. Drops, gummies and patches sold as supplements aren't those drugs.

Claims of "FDA certification" or "FDA approval" for a supplement. The FDA doesn't approve supplements before they're sold, so these claims are misleading.

Borrowed endorsements. Be skeptical when a product says it was developed or endorsed by a medical society or university, and you can only find that claim on the seller's own site.

Precise results with no study behind them. Promises like a set amount of fat burned per dose should come with a published trial. If they don't, treat them as marketing.

Before-and-after photos and testimonials. These are easy to fake or cherry-pick, as the FTC's action on fake testimonials shows.

"For research purposes" or "not for human consumption." This label on an injectable GLP-1 means it isn't meant for you, whatever the seller implies.

Pressure tactics. Countdown timers, "only 3 left" warnings and bulk bundles are sales tactics, not medical advice.

If you think a weight-loss product misled you, you can report it to the FTC at ReportFraud.ftc.gov.

Frequently Asked Questions

Does Diapason GLP-1 work?

There's no published evidence that it does. We found no studies of Diapason GLP-1 on PubMed or ClinicalTrials.gov as of September 2026. It's sold as a liquid supplement, and there's no data showing it causes weight loss or works like prescription GLP-1 medications.

Is Diapason GLP-1 FDA approved?

No. A retailer listing for the product says it is "not specifically FDA approved." The FDA doesn't approve dietary supplements before they're sold, so no supplement can honestly claim FDA approval.

What is in Diapason GLP-1?

According to a retailer listing, it contains "Meglitude GLP-1," moringa, apple cider vinegar, turmeric, ginkgo biloba extract, echinacea and probiotics, plus green tea extract, NAD and NMN. We found no published research on "Meglitude GLP-1," and none of the listed ingredients is an FDA-approved GLP-1 medication.

Are Diapason GLP-1 reviews trustworthy?

Treat them with caution. Star ratings and testimonials can't show whether a product caused weight loss, and the FTC has taken action against a weight-loss company over fake testimonials and distorted reviews. A controlled clinical trial is the only reliable way to know whether something works, and there isn't one for Diapason GLP-1.

Is Lercea GLP-1 legit?

We found no evidence it works. Lercea's own page describes its "GLP-1" ingredient as "created based on simethicone," which is an anti-gas medicine, not a GLP-1 drug. It also claims FDA certification and an Obesity Society connection that we couldn't verify anywhere outside Lercea's site.

Can you get GLP-1 medication without a prescription?

Not legitimately. The FDA-approved GLP-1 medications, including Wegovy, Zepbound and Foundayo, require a prescription. Products sold without one are either supplements that don't contain these drugs or unapproved products the FDA has warned about.

Which GLP-1 works best for weight loss?

In SURMOUNT-5, a large head-to-head trial, tirzepatide led to more average weight loss than semaglutide (20.2% versus 13.7% at 72 weeks). The best choice for you depends on your health history, how you tolerate side effects, your insurance and your budget, so it's a decision to make with your prescriber.

How much do GLP-1 medications cost in 2026?

Self-pay prices for the approved options range between $149 and $499 a month depending on the drug and dose. Savings cards can lower that with eligible commercial insurance, and eligible Medicare Part D enrollees can pay $50 a month under the Medicare GLP-1 Bridge. See our cost guide for details.

The Bottom Line: What Actually Works

For weight loss with evidence behind it: tirzepatide, semaglutide, orforglipron and liraglutide all have large published trials. They need a prescription and supervision, and they have real side effects, but they work.

For "GLP-1" drops and supplements: save your money. We found no evidence that Diapason GLP-1 or Lercea GLP-1 cause weight loss, and several of their claims don't hold up.

For budget concerns: talk to your prescriber about the lower-cost options, including pills, savings programs and Medicare coverage, before turning to a product without evidence.

The GLP-1 space keeps moving fast. Recently we've seen new pills, higher-dose injections and new Medicare coverage, with more drugs in late-stage trials. Just make sure whatever you choose is the real thing, not an expensive placebo with a clever name. And whichever option you and your prescriber land on, PeptideKit can help you keep track of every dose.

Always consult with qualified healthcare professionals before starting any peptide therapy protocol. This information is for educational purposes only and does not constitute medical advice.